Management of Hyperglycemia After Ischemic Stroke

Rationale for Active Glucose Management

• The American Heart Association/American Stroke Association guidelines recommend treating elevated glucose concentrations in the range of 140-180 mg/dL, as hyperglycemia is independently associated with infarct expansion, hemorrhagic transformation, and poor neurological outcomes 1, 3, 4, 5
• Persistent hyperglycemia (>200 mg/dL) during the first 24 hours independently predicts expansion of infarct volume and worse outcomes 3, 4

Treatment Algorithm

• For a patient with fasting glucose exceeding 140 mg/dL, insulin therapy should be initiated, with a target range of 140-180 mg/dL, according to the American College of Cardiology 1, 2
• If fasting glucose exceeds 200 mg/dL, strong consideration should be given to insulin therapy per guideline consensus 1, 3

Monitoring and Management

• The American Heart Association recommends monitoring glucose every 6 hours initially in the first 24-48 hours, and checking potassium levels before and during insulin therapy to avoid hypokalemia 2, 6
• Avoid glucose levels <80 mg/dL, as hypoglycemia may be more immediately dangerous than moderate hyperglycemia, and symptomatic hypoglycemia occurred in 21% of patients in one insulin protocol study 2, 4

Special Considerations

• At 2 days post-stroke, the patient is beyond the hyperacute phase but still within the critical window where glucose control matters, according to the American Stroke Association 3, 4
• The evidence strongly supports active glucose management with insulin, rather than observation alone, with careful monitoring to avoid hypoglycemia and electrolyte disturbances 1, 3, 4, 5